Pathogenesis of Lassa fever virus infection: I. Susceptibility of mice to recombinant Lassa Gp/LCMV chimeric virus

Virology. 2013 Aug 1;442(2):114-21. doi: 10.1016/j.virol.2013.04.010. Epub 2013 May 16.

Abstract

Lassa virus (LASV) is a BSL-4 restricted agent. To allow study of infection by LASV under BSL-2 conditions, we generated a recombinant virus in which the LASV glycoprotein (Gp) was placed on the backbone of lymphocytic choriomeningitis virus (LCMV) Cl13 nucleoprotein, Z and polymerase genes (rLCMV Cl13/LASV Gp). The recombinant virus displayed high tropism for dendritic cells following in vitro or in vivo infection. Inoculation of immunocompetent adults resulted in an acute infection, generation of virus-specific CD8(+) T cells and clearance of the infection. Inoculation of newborn mice with rLCMV Cl13/LASV Gp resulted in a life-long persistent infection. Interestingly, adoptive transfer of rLCMV Cl13/LASV Gp immune memory cells into such persistently infected mice failed to purge virus but, in contrast, cleared virus from mice persistently infected with wt LCMV Cl13.

Publication types

  • Research Support, N.I.H., Extramural

MeSH terms

  • Animals
  • Animals, Newborn
  • CD8-Positive T-Lymphocytes / immunology
  • Chronic Disease
  • Dendritic Cells / virology
  • Disease Models, Animal
  • Lassa Fever / immunology
  • Lassa Fever / pathology*
  • Lassa Fever / virology*
  • Lassa virus / genetics*
  • Lassa virus / immunology
  • Lassa virus / pathogenicity*
  • Lassa virus / physiology
  • Lymphocytic choriomeningitis virus / genetics*
  • Mice
  • Mice, Inbred C57BL
  • Recombination, Genetic*
  • Viral Envelope Proteins / genetics
  • Viral Tropism

Substances

  • Viral Envelope Proteins
  • glycoprotein gp1, lassa virus
  • glycoprotein gp2, lassa virus